10.1371/journal.pone.0032418 77 GreenR
In type 2 diabetes patients on metformin treatment, AZD5004 led to more side effects than placebo, particularly gastrointestinal in naturethough none of the side effects were serious
Interestingly, in their 2-year (aka long-term) weight loss study, 77.6% were [cis] women (with, again, a failure to include transgender and nonbinary people) and also vastly overrepresented white people at 93.1%
While this can lead to feeling fuller for longer, it can also make it harder for your digestive system to keep things moving, resulting in constipation
Baseline imaging is not routinely required for all patients
Batch-to-batch purity variability , with some community-tested batches below the claimed range